As synthetic biology reshapes the global bioeconomy, a new era of opportunity is unfolding—one driven by innovation, sustainability, and technological synergy. At CPHI & PMEC China 2025, industry leaders and scientific pioneers will gather in Shanghai to explore how synthetic biology is moving from lab-scale to large-scale production, transforming pharmaceuticals, energy, materials, and beyond.

Synthetic Biology: The Next Frontier of Biomanufacturing

Synthetic biology is no longer a distant vision—it’s a fast-growing reality. With applications ranging from vaccine development and therapeutic proteins to green chemicals and biofuels, this field is expected to exceed USD 50 billion in global market size by 2028.

At the heart of this transformation is biomanufacturing, a disruptive and sustainable production method that uses engineered biological systems to replace traditional chemical synthesis. As a key driver of the next-generation bioeconomy, biomanufacturing is now a focal point of government policies and industrial investment worldwide.

China’s Strategic Push for Synthetic Biology Innovation

China is actively accelerating its synthetic biology capabilities. Local governments have included synthetic biology in strategic emerging industry plans, establishing specialized industrial parks and funding platforms to support upstream R&D and downstream commercialization.

From policy alignment to academic-industrial integration, China is laying the groundwork to become a global leader in biomanufacturing. This momentum makes 2025 a critical inflection point for stakeholders to align, collaborate, and innovate.

CPHI China 2025: A Global Platform for Industry Exchange

As one of the largest pharmaceutical trade shows in the world, CPHI & PMEC China 2025 will serve as a key platform to showcase breakthroughs in synthetic biology and life sciences.

Among the featured events is the “Symposium on the Development Trend of Synthetic Biology from Pilot Scale to Commercialization,” organized by the China Association for Pharmaceutical Equipment (CAPE). This high-level forum will also mark the official launch of CAPE’s Synthetic Biology and Biomanufacturing Committee, reinforcing CAPE’s role in resource integration, technological guidance, and policy advocacy.

Keynote Spotlight: AI-Powered Enzyme Evolution and Industrial Application

A major highlight of the event will be the expert keynote from Dr. Guangyu Yang, Chairman and CTO of Hzymes. Dr. Yang will deliver a presentation titled:

“The Golden Era of Synthetic Biology: AI-Assisted Directed Enzyme Evolution and Its Industrial Applications”

📍  Time: June 25, 2025 (Wednesday) | 16:05–16:35
📍  Location: Room M41, Hall N2, Shanghai New International Expo Center

His talk will explore how artificial intelligence is revolutionizing enzyme design and optimization, enabling faster, smarter, and more precise development of biocatalysts for industrial-scale biomanufacturing.

Driving Synergy Across Industry and Innovation

The symposium will bring together a diverse network of stakeholders—R&D experts, biotech firms, pharmaceutical manufacturers, investors, and policymakers. Discussions will cover the full value chain: from strain engineering and process scale-up to regulatory pathways and market readiness.

This collaborative spirit is what makes synthetic biology more than a science—it’s a movement toward building a more sustainable, efficient, and intelligent bioindustrial future.

Join Us at CPHI China 2025

Whether you're a startup innovator, a pharmaceutical executive, a researcher, or an investor, this is a rare opportunity to be part of a transformational dialogue on the future of synthetic biology and biomanufacturing.

📅  Date: June 25, 2025
🕒  Time: 13:30–17:00
📍  Venue: Shanghai New International Expo Center, N2 Hall, Meeting Room M41

🌐  Join the symposium, connect with industry leaders, and witness the birth of CAPE’s Synthetic Biology and Biomanufacturing Committee. Together, we’re shaping the future of biomanufacturing.